These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36023681)

  • 1. Parke, Davis & Co.
    South Med Rec; 1882 Jan; 12(1):36. PubMed ID: 36023681
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials and the origins of pharmaceutical fraud: Parke, Davis & Company, virtue epistemology, and the history of the fundamental antagonism.
    Gabriel JM; Holman B
    Hist Sci; 2020 Dec; 58(4):533-558. PubMed ID: 32713203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stanback v. Parke, Davis and Co.
    U.S. Court of Appeals, Fourth Circuit
    Fed Report; 1981 Aug; 657():642-7. PubMed ID: 11648466
    [No Abstract]   [Full Text] [Related]  

  • 4. Parke, Davis & Co.
    South Med Rec; 1885 Jan; 15(1):39. PubMed ID: 36023924
    [No Abstract]   [Full Text] [Related]  

  • 5. Parke, Davis & Co.
    South Med Rec; 1882 Feb; 12(2):76. PubMed ID: 36023713
    [No Abstract]   [Full Text] [Related]  

  • 6. Parke, Davis & Co.
    South Med Rec; 1888 Feb; 18(2):78. PubMed ID: 36022930
    [No Abstract]   [Full Text] [Related]  

  • 7. Liberality of Parke, Davis & Co.
    South Med Rec; 1887 Apr; 17(4):174-175. PubMed ID: 36022771
    [No Abstract]   [Full Text] [Related]  

  • 8. PHYLACOGENS, THE JOURNAL A. M. A., AND PARKE, DAVIS & CO.
    Cal State J Med; 1913 May; 11(5):173. PubMed ID: 18735905
    [No Abstract]   [Full Text] [Related]  

  • 9. Frank G. Ryan Elected President of Parke, Davis & Co.
    Buffalo Med J; 1907 Aug; 63(1):47-48. PubMed ID: 36888479
    [No Abstract]   [Full Text] [Related]  

  • 10. PD-140248 (Parke-Davis & Co).
    Steiert M; Schmitz FJ
    IDrugs; 2000 Feb; 3(2):223-7. PubMed ID: 16107942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of phenytoin.
    Glazko AJ
    Ther Drug Monit; 1986; 8(4):490-7. PubMed ID: 3547783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parke, Davis & Company's Vaccine Virus.
    Parke, Davis & Co.
    Buffalo Med J; 1902 Jan; 41(6):441. PubMed ID: 36885437
    [No Abstract]   [Full Text] [Related]  

  • 13. Chloramphenicol manufacture by Parke, Davis at Hounslow.
    W GN
    Manuf Chem Aerosol News; 1950 Jun; 21(6):235-7. PubMed ID: 15422943
    [No Abstract]   [Full Text] [Related]  

  • 14. Presentation of the warner-lambert parke-davis award to david a. Clayton and Michael a. Gimbrone, jr: 1982.
    Marchesi VT
    Am J Pathol; 1982 Sep; 108(3):263-5. PubMed ID: 19970122
    [No Abstract]   [Full Text] [Related]  

  • 15. Enoxacin (Parke-Davis).
    Infection; 1986; 14 Suppl 3():S181-220. PubMed ID: 3463541
    [No Abstract]   [Full Text] [Related]  

  • 16. Presentation of the Parke-Davis Award to Carl W. Pierce 1979.
    Anderson R
    Am J Pathol; 1980 Jan; 98(1):7-8. PubMed ID: 6985774
    [No Abstract]   [Full Text] [Related]  

  • 17. False positive skin tests with Parke-Davis Aplisol.
    Blackshear J; Bravo E; Gesink D; Davies SF; Iber C; Johnson JR
    Am Rev Respir Dis; 1983 Feb; 127(2):254. PubMed ID: 6830044
    [No Abstract]   [Full Text] [Related]  

  • 18. Presentation of the Parke-Davis Award to Dr. Peter M. Henson.
    Ward PA
    Am J Pathol; 1980 Dec; 101(3):491-2. PubMed ID: 7004204
    [No Abstract]   [Full Text] [Related]  

  • 19. Presentation of the Warner-Lambert Parke-Davis award to Dr. Michael W. Lieberman.
    Becker FF
    Am J Pathol; 1981 Sep; 104(3):193-5. PubMed ID: 7027803
    [No Abstract]   [Full Text] [Related]  

  • 20. Gabapentin (Neurontin, Parke-Davis).
    Fisher K; McPherson ML
    Am J Hosp Palliat Care; 1997; 14(6):311-2. PubMed ID: 9392729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.